[Non-immunologic factor: immunosuppressive drug-induced nephrotoxicity]

Area of Science:

• Nephrology
• Immunology
• Pharmacology

Context:

• Immunosuppressant-induced nephrotoxicity is a major cause of long-term kidney graft loss.
• Cyclosporine A (CsA) is a common immunosuppressant associated with significant nephrotoxicity.
• Magnesium (Mg) deficiency exacerbates CsA nephrotoxicity, but the underlying mechanisms require elucidation.

Purpose:

• To investigate the protective mechanisms of Mg supplementation against CsA-induced nephrotoxicity.
• To examine the role of the renin-angiotensin system (RAS) in CsA nephrotoxicity and Mg's potential modulation of it.
• To elucidate the impact of Mg on CsA-induced interstitial mononuclear cell infiltration and subsequent tubulointerstitial fibrosis.

Summary:

• CsA administration in rats led to impaired renal function, increased tubulointerstitial fibrosis, and elevated expression of chemoattractant proteins (osteopontin, MCP-1).
• Mg supplementation ameliorated CsA-induced renal dysfunction and fibrosis, significantly reducing inflammatory cell infiltration.
• Angiotensin-converting enzyme inhibitor (ACEI) showed limited protective effects, suggesting Mg's benefits are largely independent of the RAS.

Impact:

• Mg supplementation effectively prevents CsA-induced nephrotoxicity by inhibiting inflammatory cell influx and fibrosis, independent of the RAS.
• These findings highlight Mg as a potential therapeutic agent to mitigate long-term kidney damage in patients receiving CsA.
• Understanding this mechanism provides a basis for developing novel strategies to improve kidney graft survival and patient outcomes.